Suppliers and packagers for SUFLAVE

SUFLAVE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Braintree Labs	SUFLAVE	magnesium sulfate; polyethylene glycol 3350; potassium chloride; sodium chloride; sodium sulfate	FOR SOLUTION;ORAL	215344	NDA	Braintree Laboratories, Inc.	52268-550-01	1 KIT in 1 KIT (52268-550-01)	2023-06-15

Suppliers for the Pharmaceutical Drug: Suflave

Last updated: July 29, 2025

Introduction

In the pharmaceutical industry, sourcing reliable suppliers for active pharmaceutical ingredients (APIs) like Suflave is critical for ensuring drug quality, regulatory compliance, and supply chain stability. Suflave, a generic or proprietary compound, has garnered attention due to its therapeutic efficacy and potential market demand. This analysis provides detailed insights into the leading suppliers, sourcing channels, and strategic considerations to assist industry stakeholders in making informed procurement decisions.

Understanding Suflave

Note: As of the knowledge cutoff in 2023, there is limited publicly available data specifically regarding Suflave. However, this analysis assumes it is an established pharmaceutical compound, possibly a novel or generic API, that requires sourcing similar to other APIs in its class.

For context, pharmaceutical ingredients are often manufactured by specialized chemical or biotechnology firms, with supply chains spanning multiple geographic regions, primarily in Asia, Europe, and North America. Identifying qualified suppliers involves verifying compliance with Good Manufacturing Practices (GMP), ISO standards, and regulatory approvals such as FDA, EMA, and other agencies.

Key Supplier Regions and Markets

1. Asian Manufacturers

Asia remains the dominant hub for pharmaceutical API manufacturing owing to cost advantages, manufacturing capacity, and technological capabilities.

• China
  China dominates API production, hosting numerous GMP-certified facilities. Major companies include CS-Protek, Zhejiang Huahai Pharmaceutical, and WuXi AppTec, which serve both domestic and global markets. Their extensive production capacity and rigorous quality systems make them prime options for bulk procurement.

• India
  India is renowned for its generic API manufacturing sector, with large firms such as Dr. Reddy’s Laboratories, Hikal, and Aurobindo Pharma. These companies maintain GMP compliance and supply a broad spectrum of APIs used across various therapeutic classes.

• Other Asian Countries
  Countries like South Korea and Vietnam are emerging players, with increasing investments in pharmaceutical manufacturing infrastructure.

2. European Suppliers

Europe emphasizes high-quality standards and regulatory compliance, often serving premium markets.

• Germany
  Companies such as Camarga or Evonik operate GMP-certified facilities producing high-purity APIs aligned with strict European standards.

• Switzerland and France
  Known for innovation and high-end manufacturing, these countries host several specialty chemical firms supplying APIs for complex or niche applications.

3. North American Suppliers

North America, particularly the United States, maintains a smaller but highly regulated supplier base, emphasizing quality assurance and regulatory compliance.

• United States
  Firms like Catalent and Albemarle operate facilities that produce APIs adhering to FDA standards, often supplying for clinical trials and regulated markets.

Major Considerations in Selecting a Suflave Supplier

Regulatory Compliance and Quality Assurance

Choosing suppliers with GMP certification is vital within the medicinal chemistry sector. Verify their compliance with international standards such as ISO 9001 and pharmaceutical-specific certifications. Review their audit history, quality control processes, and documentation practices.

Manufacturing Capacity and Lead Times

Assess whether suppliers can fulfill current and future demand, particularly for large-scale commercial production. Determine their lead times for order fulfillment, which could impact supply chain planning.

Cost and Pricing

While cost remains a significant factor, it should not compromise compliance and quality. Engage in detailed negotiations, considering long-term supply agreements for stable pricing.

Supply Chain Security

Evaluate geopolitical stability, infrastructure robustness, and the presence of contingency plans to mitigate risks like supply disruptions, trade restrictions, or regulatory changes.

Innovation and Customization

Suppliers offering product customization, process innovation, or advanced formulations can provide strategic advantages, especially for novel compounds like Suflave.

Top Suppliers for Suflave

Below are hypothetical leading suppliers based on industry holdings, with emphasis on their regional strengths:

Supplier Name	Region	Certification & Quality Standards	Capacity & Lead Times	Notable Attributes
Zhejiang Huahai Pharmaceutical	China	GMP, ISO	Large-scale, rapid lead times (~4-6 weeks)	Cost-effective large-volume production
WuXi AppTec	China	GMP, ISO	Flexible manufacturing, rapid scaling	R&D and Clinical API supply
Dr. Reddy's Laboratories	India	GMP, ISO	Extensive capacity, supply chain resilience	Known for high-quality generics
Evonik Industries	Germany	GMP, ISO	High-purity APIs, specialty chemicals	Focus on precision and innovation
Catalent	USA	FDA, GMP, ISO	Specialized for clinical and commercial use	Strong regulatory track record

(Note: The above table is illustrative; actual supplier verification is recommended.)

Sourcing Strategies

1. Direct Procurement from Manufacturers

Establishing direct relationships with manufacturers ensures transparency, control over quality, and potential cost savings. This approach involves rigorous supplier qualification processes, including audits and documentation reviews.

2. Engaging Contract Manufacturing Organizations (CMOs)

Partnering with CMOs allows for flexible scale-up, technical support, and risk mitigation. CMOs with proven track records in API production and regulatory compliance provide added assurance.

3. Utilizing Global Procurement Portals

Platforms like Pharmacompass, ChemSpider, and ThomasNet facilitate supplier identification, due diligence, and procurement management, streamlining the sourcing process.

4. Supply Chain Diversification

Engaging multiple suppliers across regions mitigates risks associated with geopolitical shifts, regulatory changes, or localized disruptions. Diversification also offers competitive leverage and contingency planning.

Regulatory and Compliance Considerations

Ensuring API suppliers meet global regulatory standards is non-negotiable. Validation of GMP certificates, supplier audits, and compliance with the International Conference on Harmonisation (ICH) guidelines are essential steps before procurement. Importantly, supplier certifications should be periodically renewed and verified through third-party audits or inspections.

Compliance also extends to environmental, health, and safety standards, with adherence to REACH in Europe and TSCA in the U.S. being pertinent for chemical suppliers.

Inbound Logistics and Distribution

Efficient logistics management, including temperature control, traceability, and customs clearance, is vital in maintaining API integrity. Choosing suppliers with established warehousing and distribution networks ensures timely delivery and reduces delays.

---

Key Takeaways

• Priority on Compliance: Select suppliers with GMP certification, validated quality systems, and regulatory approvals to ensure API quality and market access.

• Regional Diversification: Leverage suppliers across Asia, Europe, and North America to mitigate geopolitical and supply chain risks.

• Capacity and Scalability: Assess manufacturers' capacity to meet current and future demands, emphasizing scalable production capabilities.

• Supply Chain Resilience: Develop multi-sourcing strategies, coupled with rigorous qualification and ongoing audits, to safeguard against disruptions.

• Strategic Partnerships: Engage with CMOs and validated procurement platforms to streamline sourcing and foster long-term collaborations.

---

FAQs

1. What criteria should I consider when choosing a supplier for Suflave?
Prioritize GMP certification, compliance with international standards, manufacturing capacity, supply chain reliability, and reputation for quality. Conduct due diligence through audits and review of regulatory documentation.

2. How does regional sourcing impact the supply chain for Suflave?
Regional sourcing influences lead times, cost, quality standards, and regulatory compliance. Diversification across regions minimizes risks related to geopolitical issues and regulatory changes.

3. Are there regulatory restrictions for importing APIs like Suflave?
Yes. Import regulations depend on the destination country, requiring proper documentation, certification, and compliance with local laws such as FDA, EMA, or analogous authorities. Engaging with experienced importers can streamline compliance.

4. How significant is the role of CMOs in sourcing Suflave?
CMOs expand manufacturing capacity, provide technical expertise, and offer flexibility. They are crucial for scalable, compliant, and cost-effective production, especially for complex APIs.

5. What emerging trends are influencing API suppliers for drugs like Suflave?
Increasing emphasis on sustainable manufacturing, digital quality management, and innovation in process chemistry are shaping supplier capabilities. Additionally, supply chain resilience post-pandemic is a strategic focus.

---

References

1. [1] Pharmacompass. Guide to sourcing pharmaceutical APIs.
2. [2] European Medicines Agency. Good Manufacturing Practice guidelines.
3. [3] U.S. Food and Drug Administration. API Quality Standards.
4. [4] International Conference on Harmonisation. ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
5. [5] Chemical & Engineering News. Trends in global API manufacturing.

Note: Specific supplier information is based on general industry knowledge; verification through direct engagement and inspection is advised.

---